Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Asian ADRs Tumble Lower in Monday Trading

08/16/2021 | 10:39am EDT


© MT Newswires 2021
All news about ATAI LIFE SCIENCES N.V.
10/19ATAI LIFE SCIENCES N : Launches atai Impact, a Philanthropic Program to Harness the Power ..
AQ
10/19Atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness the Power o..
CI
10/18ATAI LIFE SCIENCES N : HC Wainwright Starts Atai Life Sciences at Buy with $40 Price Targe..
MT
10/11ATAI LIFE SCIENCES N : Chymia Form Precision Psychiatry Company to Develop Targeted Depres..
MT
10/11ATAI LIFE SCIENCES N : announces the launch of PsyProtix, to develop a precision psychiatr..
AQ
10/11Atai Life Sciences Announces the Launch of Psyprotix, to Develop A Precision Psychiatry..
CI
10/05Asian ADRs Move Higher in Tuesday Trading
MT
10/01Asian ADRs Sharply Lower Friday as China Education Stocks Slide
MT
09/21ATAI LIFE SCIENCES N : Unit Starts Dosing in Phase 1/2a Trial of Ibogaine in Opioid Use Di..
MT
09/21ATAI LIFE SCIENCES N : DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogain..
AQ
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 18,3 M - -
Net income 2021 -114 M - -
Net cash 2021 383 M - -
P/E ratio 2021 -18,6x
Yield 2021 -
Capitalization 2 361 M 2 361 M -
EV / Sales 2021 108x
EV / Sales 2022 26 473x
Nbr of Employees 35
Free-Float 90,3%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 15,25 $
Average target price 30,09 $
Spread / Average Target 97,3%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando Gutíerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.0.00%2 361
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 076
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455